Log In
BCIQ
Print this Print this
 

ATX2417

  Manage Alerts
Collapse Summary General Information
Company Atopix Therapeutics Ltd.
DescriptionProstaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2; CRTH2; GPR44; DP2) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2) (CRTH2) (GPR44) (DP2) (CD294)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat Th2-mediated diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today